Select Page

The global extra corporeal membrane oxygenation (ecmo) market is expected to rise with an impressive CAGR and generate the highest revenue by 2026. Fortune Business Insights™ in its latest report published this information. The report is titled “Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market Size, Share and Global Trend By Product (Extracorporeal CO2 Machines, Disposables), Application (Chronic Pulmonary Obstructive Disease, Acute Respiratory Distress Syndrome, Bridge to Transplant), Access (Venovenous Access, Arteriovenous Access), End Users (Clinics, Ambulatory Surgery Centres, Hospitals) and Geography Forecast till 2025”. The report discusses research objectives, research scope, methodology, timeline and challenges during the entire forecast period. It also offers an exclusive insight into various details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies.

For more information, Get sample pdf @

The report provides a 360-degree overview of the market, listing various factors restricting, propelling, and obstructing the market in the forecast duration. The report also provides additional information such as interesting insights, key industry developments, detailed segmentation of the market, list of prominent players operating in the market, and other extra corporeal membrane oxygenation (ecmo) market trends. The report is available for sale on the company website.

Top Key Players Covered:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the global Extra Corporeal Membrane Oxygenation (ECMO) market. Some of the companies operating the global ExtraCorporeal Membrane Oxygenation Market are;

Maquet Holding B.V. & Co. Kg
Microport Scientific Corporation
Terumo Cardiovascular Systems Corporation
Medos Medizintechnik AG
Nipro Medical Corporation
Sorin Group, Ivanova PLC
Xenios AG, Getinge A,
Origen Biomedical GmbH
ALung Technologies, Inc.
Euro sets
Rapid adoption of digitalization among practitioners and patients is likely to fuel the demand in the global Extra Corporeal Membrane Oxygenation (ECMO) market. Additionally, increasing per capita income and rising living standards is expected to drive the global ExtraCorporeal Membrane Oxygenation Market during the forecast period 2018-2025.

However, high cost associated with the devices and lack of skilled professional to operate the system are a few factors that may hamper the growth in the global Extra Corporeal Membrane Oxygenation (ECMO) market.

In-Depth Regional Analysis:

Geographically, the global extracorporeal membrane oxygenation market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The global extracorporeal membrane oxygenation market dominated by North America and the region is likely to continue to dominate during the forecast year owing to the rise in lifestyle related to cardiovascular diseases.

View press release for more information @

Regional Analysis for Extra Corporeal Membrane Oxygenation (ECMO) Market:

North America (the USA and Canada)
Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
Latin America (Brazil, Mexico and Rest of Latin America)
Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)
Other Exclusive Reports:

Medical Equipment Financing Market

Magnetic Resonance Imaging Equipment Market